On January 1, Alexis McKee, MD and Rong Mei Zhang, MD had their review titled “Sickeningly Sweet: Infectious Complications of Diabetes” published in the “Clinical Microbiology Newsletter.” Diabetes mellitus is incredibly common in the United States and has a high occurrence of infectious complications. These complications cause an increase in morbidity, mortality, and utilization of the […]
On December 19, Alexis M. McKee, MD, CDCES, published an article on “EndocrineWeb,” titled “Is Continuous Glucose Monitoring for You?” The first continuous glucose monitor (CGM) came to existence in the early 2000s. The prior method of blood sugar testing at the time was fingerstick glucose reading. “By 2016, the accuracy of CGM sensors was so […]
On September 13, Alexis M. McKee, MD, CDCES had an article published on “Endocrine Web,” titled “What Is Insulin Glargine and What Are Its Side Effects?” Insulin glargine is a long-acting insulin, sometimes referred to as basal. When glargine was discovered, it was a game-changer in diabetes management because it allowed those with diabetes to stop using […]
Washington University School of Medicine recently received a two-year grant of $360,000 from JDRF to fund research testing the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during care with insulin and with the addition of a sodium glucose transporter inhibitor drug. Biosense is a non-invasive option to capillary […]
On September 12, Alexis McKee, MD published an article on “EndocrineWeb,” titled “What Is the Peak Time for NPH Insulin?” “Insulin is a lifesaving hormone that is necessary for cells in your body to absorb sugar (glucose). Depending on the type of diabetes mellitus a person has, there can be a complete absence of insulin (type […]